Shebin El Kom Teaching Hospital is a prominent public medical facility located in Shibin El Kom, Menofia Governorate, Egypt. It serves as a comprehensive center, performing thrombectomy procedures and is part of the official stroke network.

Shebin El Kom Teaching Hospital offers a wide range of medical services across various departments, including:​

• Dentistry

• Obstetrics and Gynecology

• Surgery

• Pediatrics

• Internal Medicine

• Ear, Nose, and Throat (ENT)

• Dermatology

• Neurology

• Ophthalmology

• Urology

• Orthopedics

• Cardiology

1. Clinical Excellence & Patient Care:

• The hospital is recognized for its stroke care excellence, being part of Egypt’s official stroke network.

• It consistently receives the Diamond Award from the Angels Initiative, proving a strong commitment to quality and speed in stroke treatment.

• Offers a 24/7 emergency service and operates round-the-clock with specialized units and intensive care support.

2. Medical Training & Education:

• Affiliated with the General Organization for Teaching Hospitals and Institutes (GOTHI), supporting a learning-rich, evidence-based medical environment.

• Functions as a training center under the Egyptian Medical Board, enhancing quality through continuous professional development and research.

3. Infrastructure & Technology:

• The hospital is equipped with advanced diagnostic and treatment tools, though some reports mention occasional equipment maintenance issues (e.g., CT machine downtime).

• Includes isolation rooms, blood bank, intensive care units (ICU), and stroke intervention tools like thrombectomy equipment.

Vision: To be a leading healthcare institution recognized for excellence in medical education, patient care, and community service.

Mission: To deliver high-quality, patient-centered healthcare services across a broad spectrum of medical specialties, while fostering a culture of continuous learning and research.

The hospital has consistently achieved the Diamond award level in the Angels Initiative awards from Q2 2023 through Q4 2024, reflecting its commitment to high-quality stroke care.